Executive Vice President, Strategy and Corporate Development
Marc Stapley joined Illumina in 2012 and holds the role of Executive Vice President, Strategy and Corporate Development,
responsible for corporate strategy, corporate & business development and global infrastructure. Previously,
Stapley served as Chief Administrative Officer with responsibility for all G&A functions. Prior to that,
he served as Senior Vice President and Chief Financial Officer. He is also a member of Illumina’s executive
management team, which is responsible for directing all aspects of company strategy, planning, and operations.
Stapley was previously Senior Vice President, Finance at Pfizer and was responsible for global financial processes and systems, leading integration efforts in both the Wyeth and King Pharmaceutical acquisitions and providing oversight to the company’s largest technology investment program. Prior to Pfizer, he served in a variety of senior finance roles at Alcatel-Lucent, including Americas CFO. He also worked as Finance Director and Controller for several groups at Cadence Design Systems. Stapley is currently a member of the board of directors for Glaukos and Helix.
Stapley began his career as an Auditor at Coopers & Lybrand. He holds a First Class BSc (Honors) in Mathematics from The University of Reading (England) and is a member of the Institute of Chartered Accountants in England and Wales.